PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Sweat IT is a fitness studio in London, which provides supreme high-intensity training experience with the hardest workouts. The UK fitness industry continues to grow high at a value of over £5 billion because of increasing demand for a healthy lifestyle. Sweat IT redefines this with healthy eating and exercise. The company has the vision to take its business growth to the next level and become the leader of boutique fitness. They have partnered with Gympass, the world’s leading corporate fitness platform to deliver high-intensity fitness classes to London based corporate clients. Till date, they have had over 50,000 class bookings with more than 13,000 Instagram followers and a database of 10,000 customers. The company intends on using the investment for marketing and product branding and next-level growth. They are also looking to fund their second studio in London and have ear-marked a potential site in the City.
days to go:
Expired
investment:
£211,220
Flooring Hut is a UK-based technology company that aims to disrupt the UK flooring industry valued at £2bn in 2017. Touted as the smarter way to buy new carpets & flooring, Flooring Hut has made 24,000+ online sales across domestic and trade sectors by building a huge network of independent installers. The company's USP is to connect a disjointed market and allow customers access to value products, samples, leading brands and a suitable, vetted local installer to perform the work. The key to its success to date has been a consistent and reliable mix of pricing, availability, and selection. Till date, the company has 786 registered trade customers, 140+ Flooring Hut Installer Network of members, and 12,000 products available for sale. With the proceeds, the company will develop its self-service platform functionality for customers and expand its reach on social media and affiliate marketing.
days to go:
Expired
investment:
£57,077
nu:move Group is an award-winning Hybrid nationwide online estate agency. The company offers its customers a simple, online process to sell and let their property. The business is built on an ethos of modern innovation and traditional values by blending online and high street estate agency services seamlessly. The company offers a full set of estate agency services and affordable sales packages. nu:move Group has marketed more than 10,000 properties globally that are worth £3Bn and has received a 5 Star Trust Pilot Rating. The company has won The Negotiator 'Hybrid Estate Agent of the Year Award 2019.' 40% of the investment will be used for brand awareness, 30% for technology, 20% for franchise network training and expansion, and 105 for staffing at nu:move HQ.
days to go:
Expired
investment:
£153,342
Her.9 is a Direct-To-Consumer (DTC) female technology brand that caters to the needs of women during pregnancy. It cites research arguing that up to 40% of women taking prenatal vitamins may not be able to absorb the folic acid within the UK’s leading pregnancy brand. Her.9 aims to resolve this by employing DUOCAP technology. The company asserts that DUOCAP is a capsule-in-capsule delivery system which contains solubilised prebiotics in the outer capsule and probiotics in the inner capsule. The prebiotic releases immediately and the probiotic releases later allowing for targeted supplement delivery in the body. The prenatal supplements market is set to be worth $56 billion globally by 2024. Her.9 aims to be a notable contender in this segment. The company is raising investment to build its already established partnerships and execute its marketing strategy effectively.
days to go:
Expired
investment:
£215,946
University compare is a higher education comparison service. It's a digital marketplace that allows universitys and students to connect. Since 2015 they have hit their last two annual revenue targets. They are looking to use the funding to scale up.
days to go:
Expired
investment:
£250,300
PCL Health is a Business-to-Business (B2B) Software-as-a-Service (SaaS) entity that aims to bring hospital-level care to anyone remotely. It asserts that the correct use of remote monitoring can reduce mortality by up to 45%. PCL Health intends to become a contender in the remote healthcare market that is set to touch $30 billion by 2023. It has developed CE rated medical-grade devices that use health algorithms combined with sensors and its proprietary range of apps to allow family members to proactively monitor the health of their loved ones, alongside carers and doctors, remotely. PCL Health has completed two pilots with 65 people and received a Letter Of Intent (LOI) from a National Health Service (NHS) Trust for a clinical trial. It won the 'Innovative Startup' competition at the 2019 Healthcare Unblocked event. PCL Health will use the investment for technology enhancement, running further pilot studies, and working capital.
days to go:
Expired
investment:
£394,680
An online marketplace to buy and sell residential investment properties for those looking to generate an extra income. Vesta has sold 104 properties valued at £22m since launching in 2018. Properties listed contain full documents including tenancy history, due diligence, 360-degree photos and videos, valuations and investment projections. Sellers can list various new or existing sites and buyers can range from sole investors to institutions.
Vesta generates revenue by charging fees to both sellers and buyers. Various payment options are available to sellers and optional fees are charged to those who wish to host viewings for their properties. Buyers are charged a fixed fee after an offer is accepted. Vesta is now raising funds to expand their team, website and property portfolio by increasing brand awareness from marketing campaigns.
days to go:
Expired
investment:
£622,705
